Amylin says FDA wants more testing on Bydureon - BusinessWeek

[INCIID News Feed]

<img alt="" height="1" width="1" />
Amylin says FDA wants more testing on Bydureon
BusinessWeek
Amylin Pharmaceuticals Inc. and its partners said Tuesday that the Food and Drug Administration declined to approve the potential diabetes drug, Bydureon, saying it wants more testing done. The FDA had been expected to render a decision on the drug as ...
FDA seeks more data on Amylin, Lilly diabetes drugReuters
Amylin, Alkermes Once-Weekly Diabetes Drug Fails to Win FDA ApprovalXconomy
FDA Disaster For Diabetes DrugForbes (blog)
Investor's Business Daily -San Diego Union Tribune -msnbc.com
all 67 news articles &raquo;


More...